home | contact | site map | terms

• Press Releases                    
• Fact Sheets                    
• Visual Material                    
• Publications                    
• Useful Links                    

Press releases

The latest Coartem^® and Coartem^® Dispersible news

	Novartis delivers 250,000,000th Coartem® treatment and becomes first healthcare company to join United Against Malaria partnership July 2009
	Scientists who developed Novartis Coartem® and Glivec® receive 2009 ''European Inventor of the Year'' awards May 2009
	Coartem® receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US April 8 2009
	Novartis and Medicines for Malaria Venture launch Coartem® Dispersible, the first ACT* developed for children suffering from malaria Jan 2009
	Novartis announces 20% average reduction in price of malaria drug Coartem® to further accelerate access in malaria-endemic regions April 2008